Skip to main content
profile image
Selected Works of Kathleen Shannon Dorcy
Article
Survival Time is Problematic as an Indicator of an anti- AML Drug’s Effectiveness
Clinical Lymphoma, Myeloma & Leukemia (2017)
  • Carole Shaw, Fred Hutchinson Cancer Research Center
  • Shelly Hager, Fred Hutchinson Cancer Research Center
  • Mary-Elizabeth Percival, University of Washington
  • Roland Walter, Fred Hutchinson Cancer Research Center
  • Pamela Becker, University of Washington
  • Kathleen Shannon-Dorcy, University of Washington
  • Elihu Estey, University of Washington
  • Kelda Gardner, University of Washington
Link
Disciplines
Publication Date
January 9, 2017
DOI
10.1016/j.clml.2017.07.053
Citation Information
Carole Shaw, Shelly Hager, Mary-Elizabeth Percival, Roland Walter, et al.. "Survival Time is Problematic as an Indicator of an anti- AML Drug’s Effectiveness" Clinical Lymphoma, Myeloma & Leukemia Vol. 17 (2017)
Available at: http://works.bepress.com/kathleen_shannondorcy/14/